Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

( NewsNation) — Shares in some pharmaceutical and biotechnology companies, including those that manufacture vaccines, fell ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...

U.S. stocks fell to their worst loss since Election Day as the boost that Wall Street got from last week’s victory for Donald ...